IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1713
-0.0248 (-12.65%)
Mar 31, 2025, 2:35 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $13.92 million as of March 31, 2025. Its market cap has decreased by -74.27% in one year.
Market Cap
13.92M
Enterprise Value
7.85M
1-Year Change
-74.27%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $13.92M, a decrease of -92.58%. That is a compound annual growth rate of -50.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 15.93M | -14.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |